78 related articles for article (PubMed ID: 1810681)
1. The prognostic and economic implications of a strategy to detect and treat asymptomatic ischemia: the Atenolol Silent Ischemia Trial (ASIST) protocol.
Pepine CJ; Cohn PF; Deedwania PC; Gibson RS; Gottlieb SO; Handberg E; Hill JA
Clin Cardiol; 1991 Jun; 14(6):457-62. PubMed ID: 1810681
[TBL] [Abstract][Full Text] [Related]
2. Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST).
Pepine CJ; Cohn PF; Deedwania PC; Gibson RS; Handberg E; Hill JA; Miller E; Marks RG; Thadani U
Circulation; 1994 Aug; 90(2):762-8. PubMed ID: 8044945
[TBL] [Abstract][Full Text] [Related]
3. Anti-ischemic effects of atenolol versus nifedipine in patients with coronary artery disease and ambulatory silent ischemia.
Deedwania PC; Carbajal EV; Nelson JR; Hait H
J Am Coll Cardiol; 1991 Mar; 17(4):963-9. PubMed ID: 1999634
[TBL] [Abstract][Full Text] [Related]
4. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
[TBL] [Abstract][Full Text] [Related]
5. The Asymptomatic Cardiac Ischemia Pilot (ACIP) study: design of a randomized clinical trial, baseline data and implications for a long-term outcome trial.
Pepine CJ; Geller NL; Knatterud GL; Bourassa MG; Chaitman BR; Davies RF; Day P; Deanfield JE; Goldberg AD; McMahon RP
J Am Coll Cardiol; 1994 Jul; 24(1):1-10. PubMed ID: 8006249
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic rationale for the management of silent ischemia.
Fox KM; Mulcahy DA
Circulation; 1990 Sep; 82(3 Suppl):II155-60. PubMed ID: 2203562
[TBL] [Abstract][Full Text] [Related]
7. Silent myocardial ischemia after acute myocardial infarction.
Van der Wall EE; Manger Cats V; Bruschke AV
Am J Cardiol; 1992 Mar; 69(7):19B-24B. PubMed ID: 1543137
[TBL] [Abstract][Full Text] [Related]
8. [Characteristics and clinical significance of silent myocardial ischemia during ambulatory electrocardiographic monitoring in patients with ischemic heart disease].
Tomita F
Hokkaido Igaku Zasshi; 1990 Nov; 65(6):583-94. PubMed ID: 2265819
[TBL] [Abstract][Full Text] [Related]
9. Silent ischemia: a clinical update.
Valle GA; Lemberg L
Chest; 1990 Jan; 97(1):186-91. PubMed ID: 2295236
[TBL] [Abstract][Full Text] [Related]
10. Current concepts of silent myocardial ischemia.
Bleske BE; Shea MJ
Clin Pharm; 1990 May; 9(5):339-57. PubMed ID: 1972045
[TBL] [Abstract][Full Text] [Related]
11. Role of diltiazem in the treatment of silent myocardial ischemia.
Waters D; Juneau M; Baird M; Klinke P; Warnica W; Chin C; Théroux P
J Cardiovasc Pharmacol; 1991; 18 Suppl 9():S15-20. PubMed ID: 1725537
[TBL] [Abstract][Full Text] [Related]
12. [Long-term therapy of stress angina pectoris by a single daily administration of 120 mg isosorbide dinitrate in retard form. Comparison of monotherapy and combination therapy with atenolol and nifedipine].
Blasini R; Brügmann U; Reiniger G; Rudolph W
Herz; 1985 Jun; 10(3):163-71. PubMed ID: 3926613
[TBL] [Abstract][Full Text] [Related]
13. Silent myocardial ischemia: diagnosis, clinical significance and management.
Stern S; Tzivoni D
Herz; 1987 Oct; 12(5):318-27. PubMed ID: 3315917
[TBL] [Abstract][Full Text] [Related]
14. Circadian variation of the total ischemic burden and influence by beta-blocking agents.
Fox KM; Mulcahy DA
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S100-4. PubMed ID: 11527111
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance contrast enhancement with gadolinium-DTPA in patients with angina and angiographically normal coronary arteries: effect of chronic beta-blockade.
Rossetti E; Fragasso G; Mellone R; Vanzulli A; Del Maschio A; Chierchia SL
Cardiologia; 1999 Jul; 44(7):653-9. PubMed ID: 10476591
[TBL] [Abstract][Full Text] [Related]
16. Ischemia during ambulatory monitoring as a prognostic indicator in patients with stable coronary artery disease.
Mulcahy D; Husain S; Zalos G; Rehman A; Andrews NP; Schenke WH; Geller NL; Quyyumi AA
JAMA; 1997 Jan 22-29; 277(4):318-24. PubMed ID: 9002495
[TBL] [Abstract][Full Text] [Related]
17. Exercise-induced symptomatic and asymptomatic myocardial ischemia in patients with severe coronary artery disease: focus on the efficacy and safety of gallopamil.
Zehender M; Kosscheck U; Hohnloser S; Weiss C; Meinertz T; Just H
J Cardiovasc Pharmacol; 1992; 20 Suppl 7():S57-63. PubMed ID: 1284158
[TBL] [Abstract][Full Text] [Related]
18. Heart rate, magnitude and duration of ST-segment depression in symptomatic and asymptomatic episodes of myocardial ischemia in patients with coronary artery disease recorded by Holter.
Ilić S
Acta Med Iugosl; 1989; 43(3):205-13. PubMed ID: 2741722
[TBL] [Abstract][Full Text] [Related]
19. Optimal control of myocardial ischaemia: the benefit of a fixed combination of atenolol and nifedipine in patients with chronic stable angina.
el-Tamimi H; Davies GJ
Br Heart J; 1992 Sep; 68(3):291-5. PubMed ID: 1389761
[TBL] [Abstract][Full Text] [Related]
20. Silent myocardial ischemia in patients with coronary artery disease. Possible links with diastolic left ventricular dysfunction.
Mahmarian JJ; Pratt CM
Circulation; 1990 Feb; 81(2 Suppl):III33-40. PubMed ID: 2404637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
